Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Naproxen Fares Better Than Ibuprofen In Cardiovascular-Risk Data

This article was originally published in The Tan Sheet

Executive Summary

Traditional non-selective NSAIDs, with the exception of naproxen, carry similar cardiovascular risk to COX-2 inhibitors, according to results of a study released by the Agency for Healthcare Research & Quality (AHRQ) Sept. 25
Advertisement

Related Content

Ibuprofen Safety Questioned For High-Risk Cardio Patients – Study
Ibuprofen Safety Questioned For High-Risk Cardio Patients – Study
Ibuprofen Safety Questioned For High-Risk Cardio Patients – Study
NSAID Safety Review Prompts MHRA To Pursue Product Label Updates
NSAID Safety Review Prompts MHRA To Pursue Product Label Updates
NSAID Safety Review Prompts MHRA To Pursue Product Label Updates
New EMEA NSAID Study Could Put Teeth In EU Labeling Suggestion
FDA Warns Of Ibuprofen Interference With Aspirin Cardioprotection
FDA Warns Of Ibuprofen Interference With Aspirin Cardioprotection
Traditional NSAIDs Do Not Raise Cardiovascular Risk – JAMA Review

Topics

Advertisement
UsernamePublicRestriction

Register

PS099802

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel